Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report): An article from

Author: Michele G. Sullivan
Edition:
Binding: Digital
ISBN: B0010VEHXE

Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report): An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by Thomson Gale on November 1, 2006. Get Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report): An article from diet books 2013 for free.
The length of the article is 504 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report)
Author: Michele G. Sullivan
Publication: Internal Medicine News (Magazine/Journal)
Date: November 1, 2006
Publisher: Thomson Gale
Volume: Check Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report): An article from our best diet books for 2013. All books are available in pdf format and downloadable from rapidshare, 4shared, and mediafire.

Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report): An article from Free

The length of the article is 504 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase Sullivan
Publication: Internal Medicine News (Magazine/Journal)
Date: November 1, 2006
Publisher: Thomson Gale
Volume:

Related Diet Books 2013